CCL5 and type 2 diabetes mellitus: To assess the performance of CCL5 and serpin E1 as potential biomarkers for PCAND, we measured their concentrations in the peripheral blood of patients diagnosed with either PCAND (n = 8) or T2DM (n = 13).